2017
DOI: 10.1007/s40257-017-0309-6
|View full text |Cite
|
Sign up to set email alerts
|

Comment on: “A Unique Clinicopathological Manifestation of Fungal Infection: A Case Series of Deep Dermatophytosis in Immunosuppressed Patients”

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2017
2017
2024
2024

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(2 citation statements)
references
References 4 publications
0
2
0
Order By: Relevance
“…Although there is no standardized treatment for deep dermatophytosis, systemic antifungals such as terbinafine, fluconazole, and itraconazole have been reported to be efficacious. 4,9 Clinicians should remain suspicious of fungi as a potential cause of deep-tissue infection in both immunocompromised and immunocompetent patients. Fungal culture or polymerase chain reaction should be performed to confirm pathogen speciation.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Although there is no standardized treatment for deep dermatophytosis, systemic antifungals such as terbinafine, fluconazole, and itraconazole have been reported to be efficacious. 4,9 Clinicians should remain suspicious of fungi as a potential cause of deep-tissue infection in both immunocompromised and immunocompetent patients. Fungal culture or polymerase chain reaction should be performed to confirm pathogen speciation.…”
Section: Discussionmentioning
confidence: 99%
“…Oftentimes, lymphocytes show irregular nuclear contours and may display cerebriform or convoluted nuclei, which were not seen in the histopathology of the present patient. Although there is no standardized treatment for deep dermatophytosis, systemic antifungals such as terbinafine, fluconazole, and itraconazole have been reported to be efficacious . Clinicians should remain suspicious of fungi as a potential cause of deep-tissue infection in both immunocompromised and immunocompetent patients.…”
Section: Discussionmentioning
confidence: 99%